| Target
Information |
| Name | G2/mitotic-specific cyclin B1 |
| Type of target | Research target |
| Synonyms | Cyclin B1 |
| Disease | Cardiovascular disease, unspecified [1] |
| Pathway | Cell cycle |
| p53 signaling pathway |
| UniProt ID | P14635 |
| PDB Structure | 2B9R; 2JGZ. |
| Function | Essential for the control of the cell cycle at the g2/m (mitosis) transition. |
| Sequence | MALRVTRNSKINAENKAKINMAGAKRVPTAPAATSKPGLRPRTALGDIGNKVSEQLQAKM
PMKKEAKPSATGKVIDKKLPKPLEKVPMLVPVPVSEPVPEPEPEPEPEPVKEEKLSPEPI
LVDTASPSPMETSGCAPAEEDLCQAFSDVILAVNDVDAEDGADPNLCSEYVKDIYAYLRQ
LEEEQAVRPKYLLGREVTGNMRAILIDWLVQVQMKFRLLQETMYMTVSIIDRFMQNNCVP
KKMLQLVGVTAMFIASKYEEMYPPEIGDFAFVTDNTYTKHQIRQMEMKILRALNFGLGRP
LPLHFLRRASKIGEVDVEQHTLAKYLMELTMLDYDMVHFPPSQIAAGAFCLALKILDNGE
WTPTLQHYLSYTEESLLPVMQHLAKNVVMVNQGLTKHMTVKNKYATSKHAKISTLPQLNS
ALVQDLAKAVAKV
|
| Target Validation | Click to Find Target Validation Information. |
| Inhibitor | 3,4-bis (indol-3-yl)maleimide derivative |  | [2] |
| 3,4-di- (4-methoxyphenyl)-1H-pyrrole-2,5-dione |  | [3] |
| 3,4-diphenyl-1H-pyrrole-2,5-dione |  | [3] |
| 3- (4-methoxyphenyl)-4-phenyl-1H-pyrrole-2,5-dione |  | [3] |
| 3- (indole-3-yl)-4-phenyl-1H-pyrrole-2,5-dione |  | [3] |
| 4- (Quinolin-3-yl)-N-p-tolylpyrimidin-2-amine |  | [4] |
| 4- (Quinolin-4-yl)-N-p-tolylpyrimidin-2-amine |  | [4] |
| AZAKENPAULLONE |  | [5] |
| GF-109203 |  | [2] |
| KENPAULLONE |  | [6] |
| RO-316233 |  | [2] |
| Thieno analogue of kenpaullone |  | [5] |
| Cross References |
3D Structure
Related Literature
On-Line
Medical Dictionary |
| Ref 1 | Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. To Reference |
| Ref 2 | Bioorg Med Chem Lett. 1998 May 5;8(9):1019-22.Design of new inhibitors for cdc2 kinase based on a multiple pseudosubstrate structure. To Reference |
| Ref 3 | J Med Chem. 2006 Feb 23;49(4):1271-81.Design, synthesis, and biological evaluation of 3,4-diarylmaleimides as angiogenesis inhibitors. To Reference |
| Ref 4 | Eur J Med Chem. 2010 Jan;45(1):379-86. Epub 2009 Oct 13.Synthesis and cytotoxic activity of 2-methylimidazo[1,2-a]pyridine- and quinoline-substituted 2-aminopyrimidine derivatives. To Reference |
| Ref 5 | Bioorg Med Chem Lett. 2004 Jan 19;14(2):413-6.1-Azakenpaullone is a selective inhibitor of glycogen synthase kinase-3 beta. To Reference |
| Ref 6 | Eur J Med Chem. 2010 Sep;45(9):4316-30. Epub 2010 Jun 30.Discovery of novel CDK1 inhibitors by combining pharmacophore modeling, QSAR analysis and in silico screening followed by in vitro bioassay. To Reference |